ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $487,224 | -10.2% | 29,983 | +2.2% | 0.00% | -25.0% |
| Q1 2024 | $542,275 | -41.8% | 29,328 | -1.4% | 0.00% | -42.9% |
| Q4 2023 | $931,504 | +48.5% | 29,751 | -1.2% | 0.01% | +40.0% |
| Q3 2023 | $627,263 | -17.9% | 30,099 | -5.6% | 0.01% | -16.7% |
| Q2 2023 | $763,933 | +15.3% | 31,897 | -9.4% | 0.01% | 0.0% |
| Q1 2023 | $662,276 | +21.5% | 35,190 | +2.7% | 0.01% | +20.0% |
| Q4 2022 | $545,276 | +1.4% | 34,251 | +4.1% | 0.01% | -16.7% |
| Q3 2022 | $538,000 | +17.0% | 32,901 | +0.7% | 0.01% | +50.0% |
| Q2 2022 | $460,000 | -41.7% | 32,674 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $789,000 | +4.2% | 32,591 | +0.5% | 0.01% | 0.0% |
| Q4 2021 | $757,000 | +39.2% | 32,427 | -0.9% | 0.01% | +50.0% |
| Q3 2021 | $544,000 | -31.7% | 32,724 | +0.3% | 0.00% | -33.3% |
| Q2 2021 | $796,000 | -11.1% | 32,629 | -6.0% | 0.01% | -25.0% |
| Q1 2021 | $895,000 | -51.5% | 34,709 | +0.5% | 0.01% | -52.9% |
| Q4 2020 | $1,847,000 | +26.9% | 34,551 | -2.0% | 0.02% | +21.4% |
| Q3 2020 | $1,455,000 | +14.1% | 35,270 | +34.1% | 0.01% | -22.2% |
| Q2 2020 | $1,275,000 | +11.3% | 26,296 | -3.0% | 0.02% | -10.0% |
| Q1 2020 | $1,146,000 | – | 27,120 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |